Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Scinai Bioservices
Jerusalem, Israelscinai.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Scinai Bioservices is a boutique CDMO specializing in biologics process development, analytical methods development, and cGMP manufacturing for early-stage drug projects. Its business is rapidly growing, having recently expanded into the US and signed its first contract with Serpin Pharma for clinical manufacturing. The company maintains a flexible, high-quality offering with regulatory compliance, serving biotech startups globally[2][4][6].
- Therapeutic areas
- ImmunologyDermatology
- Modalities
- Recombinant proteinNanobody therapyLiposomal drug delivery
- Industry
- Contract Manufacturing Organization
02
Partnerships
Ayana Pharma (liposomal encapsulated drug development services)Max Planck Society (potential NanoAb licensing)University Medical Center Göttingen (potential NanoAb licensing)
Beyond the preview
Go deeper on Scinai Bioservices.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Scinai Bioservices.